Table 3 The association between the insulinemic dietary and lifestyle indices with the incidence of insulin resistance and metabolic syndrome: the Tehran Lipid and Glucose Study.
Insulin resistance | Metabolic syndrome | |||||||
|---|---|---|---|---|---|---|---|---|
Tertiles of indices | P trend | Tertiles of indices | P trend | |||||
T1 | T2 | T3 | T1 | T2 | T3 | |||
DIR | ||||||||
Median score | − 0.04 | 0.05 | 0.18 | − 0.04 | 0.05 | 0.18 | ||
Case/Total | 38/353 | 46/351 | 54/353 | 93/549 | 89/549 | 112/549 | ||
Model 1* | 1.00 (Ref) | 1.40 (0.86–2.28) | 1.74 (1.08–2.80) | 0.023 | 1.00 (Ref) | 1.05 (0.75–1.47) | 1.41 (1.02–1.95) | 0.030 |
Model 2† | 1.00 (Ref) | 1.38 (0.85–2.26) | 1.71 (1.06–2.76) | 0.028 | 1.00 (Ref) | 1.05 (0.75–1.47) | 1.41 (1.01–1.95) | 0.032 |
Model 3‡ | 1.00 (Ref) | 1.34 (0.81–2.21) | 1.65 (1.01–2.69) | 0.047 | 1.00 (Ref) | 1.03 (0.72–1.47) | 1.32 (0.94–1.87) | 0.091 |
LIR | ||||||||
Median score | 7.60 | 10.81 | 13.37 | 3.45 | 7.67 | 11.35 | ||
Case/Total | 26/349 | 38/350 | 73/349 | 57/543 | 86/545 | 150/543 | ||
Model 1* | 1.00 (Ref) | 1.48 (0.86–2.54) | 3.23 (1.97–5.30) | < 0.001 | 1.00 (Ref) | 1.36 (0.94–1.98) | 2.76 (1.93–3.94) | < 0.001 |
Model 2† | 1.00 (Ref) | 1.51 (0.88–2.59) | 3.20 (1.95–5.25) | < 0.001 | 1.00 (Ref) | 1.39 (0.95–2.02) | 2.81 (1.96–4.02) | < 0.001 |
Model 3‡ | 1.00 (Ref) | 1.38 (0.79–2.40) | 2.85 (1.72–4.73) | < 0.001 | 1.00 (Ref) | 1.15 (0.77–1.71) | 2.87 (1.96–4.18) | < 0.001 |